PL377664A1 - Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin - Google Patents

Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin

Info

Publication number
PL377664A1
PL377664A1 PL377664A PL37766403A PL377664A1 PL 377664 A1 PL377664 A1 PL 377664A1 PL 377664 A PL377664 A PL 377664A PL 37766403 A PL37766403 A PL 37766403A PL 377664 A1 PL377664 A1 PL 377664A1
Authority
PL
Poland
Prior art keywords
benzoxazocines
monoamine
disorders
reuptake inhibitors
emesis
Prior art date
Application number
PL377664A
Other languages
English (en)
Inventor
Andrew Douglas Baxter
Original Assignee
Arakis Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0229743A external-priority patent/GB0229743D0/en
Priority claimed from GB0316914A external-priority patent/GB0316914D0/en
Application filed by Arakis Ltd. filed Critical Arakis Ltd.
Publication of PL377664A1 publication Critical patent/PL377664A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D267/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22Eight-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Noodles (AREA)
  • Valve-Gear Or Valve Arrangements (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL377664A 2002-12-20 2003-12-22 Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin PL377664A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0229743A GB0229743D0 (en) 2002-12-20 2002-12-20 Novel benzoxazocines
GB0316914A GB0316914D0 (en) 2003-07-18 2003-07-18 Novel benzoxazocines

Publications (1)

Publication Number Publication Date
PL377664A1 true PL377664A1 (pl) 2006-02-06

Family

ID=32683980

Family Applications (1)

Application Number Title Priority Date Filing Date
PL377664A PL377664A1 (pl) 2002-12-20 2003-12-22 Benzoksazocyny i ich zastosowanie jako inhibitorów wychwytu zwrotnego monoamin

Country Status (15)

Country Link
EP (2) EP1950206A1 (pl)
JP (1) JP2006522012A (pl)
AT (1) ATE404543T1 (pl)
AU (1) AU2003295171B2 (pl)
BR (1) BR0317467A (pl)
CA (1) CA2503172A1 (pl)
DE (1) DE60322947D1 (pl)
ES (1) ES2311749T3 (pl)
HK (1) HK1075896A1 (pl)
MX (1) MXPA05006653A (pl)
NO (1) NO20052308L (pl)
NZ (1) NZ539488A (pl)
PL (1) PL377664A1 (pl)
PT (1) PT1572672E (pl)
WO (1) WO2004056788A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529611C (en) 2002-12-20 2009-12-15 Pfizer Products Inc. Pyrimidine derivatives for the treatment of abnormal cell growth
BRPI0510075A (pt) * 2004-04-21 2007-10-16 Sosei R & D Ltd benzoxazocinas e seu uso terapêutico como inibidores de reabsorção de monoamina
GB0408864D0 (en) * 2004-04-21 2004-05-26 Arakis Ltd Novel benzoxazocines
GB2413322A (en) * 2004-04-21 2005-10-26 Arakis Ltd Nefopam analogues
GB0504960D0 (en) * 2005-03-10 2005-04-20 Arakis Ltd Benzoxazocines
GB0506835D0 (en) * 2005-04-04 2005-05-11 Arakis Ltd Therapeutic use of nefopam
GB0515703D0 (en) * 2005-07-29 2005-09-07 Arakis Ltd Therapeutic use of nefopam
GB0609793D0 (en) * 2006-05-17 2006-06-28 Arakis Ltd Racemisation and recycling process
JP5194607B2 (ja) * 2006-07-26 2013-05-08 大正製薬株式会社 ソーシャルインターラクションの低下予防・改善剤
CN105687185B (zh) 2009-12-15 2019-07-09 儿童医院 使用奈福泮化合物治疗侵袭型纤维瘤病和β-联蛋白介导的疾病的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830803A (en) * 1965-05-10 1974-08-20 Riker Laboratories Inc 5-loweralkyl-1-phenyl-1,3,4,6-tetrahydro-5h-benz(f)-2,5-oxazocines and 4-ones
US3978085A (en) * 1975-03-07 1976-08-31 Riker Laboratories, Inc. Process for benz[f]-2,5-oxazocines
US4166452A (en) 1976-05-03 1979-09-04 Generales Constantine D J Jr Apparatus for testing human responses to stimuli
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
GB1586578A (en) * 1977-08-05 1981-03-18 Riker Laboratories Inc Process for the preparation of 2-(n-(2-hydroxyyethyl)-n-lower alkylaminomethyl) benzhydrols
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use

Also Published As

Publication number Publication date
ATE404543T1 (de) 2008-08-15
ES2311749T3 (es) 2009-02-16
WO2004056788A1 (en) 2004-07-08
DE60322947D1 (de) 2008-09-25
NZ539488A (en) 2008-03-28
JP2006522012A (ja) 2006-09-28
BR0317467A (pt) 2005-11-16
NO20052308L (no) 2005-09-05
PT1572672E (pt) 2008-10-02
EP1950206A1 (en) 2008-07-30
MXPA05006653A (es) 2005-09-30
AU2003295171B2 (en) 2007-09-06
NO20052308D0 (no) 2005-05-11
EP1572672A1 (en) 2005-09-14
CA2503172A1 (en) 2004-07-08
AU2003295171A1 (en) 2004-07-14
EP1572672B1 (en) 2008-08-13
HK1075896A1 (en) 2005-12-30

Similar Documents

Publication Publication Date Title
HK1075896A1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
HUP0303855A2 (hu) Indazolil-szubsztituált pirrolinvegyületek mint kináz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
NZ527470A (en) Acylated indanyl amines and their use as pharmaceuticals
AU1850801A (en) The combination of a serotonin reuptake inhibitor and irindalone
GB0325956D0 (en) Novel compounds
HUP0300832A2 (hu) Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
MXPA04002067A (es) Nuevas dihidropteridinonas, procedimientos para su preparacion y su uso como medicamento.
ATE366724T1 (de) Kondensierte heterocyclische derivate
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
BG108181A (en) Novel spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
AR041299A1 (es) Derivados de pirrolidona como inhibidores de maob
CY1108808T1 (el) Ενωσεις μοτιλιδης
BG106912A (en) Diphenyl ether compounds useful in therapy
DE60224535D1 (de) Unsymmetrische zyklische diaminverbindung
NO20055206L (no) 4-(2-fenyloksyfenyl)-piperidin eller -1,2,3,6-tetrahydropyridinderivater som serotonin-reopptaksinhibitorer
DE69433148D1 (de) Tricyclische kondensierte heterocyclische Verbindungen zur Behandlung von seniler Demenz
WO2005009392A3 (en) Dihydropyrimidone inhibitors of calcium channel function
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
MX2008001778A (es) Combinacion de un agente hipnotico y un compuesto de bis arilo y heteroarilo sustituido y aplicacion terapeutica de la misma.
WO2004052858A3 (en) Inhibitors of monoamine uptake
DK1381613T3 (da) Antidepressive azaheterocyclylmethylderivater af oxaheterocyclokondenserede 1,4-benzodioxaner
PT1392700E (pt) Derivados aza-heterociclilmetilo antidepressivos de 7,8-di-hidro-1,6,9-troxa-3-aza-ciclopenta(a)naftaleno
ATE353330T1 (de) Triazolopyrimidine fungizide
WO2002088144A3 (en) ANTIDEPRESSANT AZAHETEROCYCLYLMETHYL DERIVATIVES OF 2,3-DIHYDRO-1,4-DIOXINO[2,3-f]QUINOXALINE
BR0209408A (pt) Antidepressivos de azaheterociclilmetila derivados de 7,8-dihidro-3h-6,9-dioxa-1,3-diaza-ciclopenta[a]naftal eno, método de tratamento usando tais compostos e processo para prepará-los

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)